Search
SOLACI Congress
HomeFileStructural heart disease

Structural heart disease

View Category

Structural heart disease

Redo Surgical Aortic Valve Replacement after Prior Transcatheter vs Surgical Aortic Valve Replacement: A Growing Population

Transcatheter aortic valve replacement (TAVR) has evolved since it was first implemented, and it is now also...
solaci -
Learn More
Structural heart disease

BASILICA: a Complex Strategy, Yet Safe

Coronary artery obstruction (CAO) after TAVR is rare, but it entails extremely high mortality (50% or more),...
solaci -
Learn More
Structural heart disease

Evolute Low Risk at 3 Years: Promising Outcomes

Transcatheter aortic valve replacement has shown important benefits but one of its biggest challenges is showing its...
solaci -
Learn More
Structural heart disease

Sex-Related Differences in Clinical Outcomes after Transcatheter Tricuspid Valve Intervention

We are aware of sex related differences when it comes to comorbidities, physiopathology and disease evolution in...
solaci -
Learn More
Structural heart disease

Is There a Way to Reduce the Need for Permanent Pacemaker Implantation in Self-Expanding Valves?

We are well aware of the benefits of TAVR in different scenarios, but the need for permanent...
solaci -
Learn More
Structural heart disease

High Implantation of Self-Expanding Valves in the Aortic Position or Cusp Overlapping: Should It Be the New “Gold Standard”?

Transcatheter aortic valve replacement (TAVR) has been proving its benefit in different scenarios for two decades now....
solaci -
Learn More
Chronic Ischemic cardiopathy

Clinical Impact of Coronary Artery Disease on Results After TAVR

Coronary artery disease (CAD) coexists with aortic stenosis in about half the patients who suffer the latter....
solaci -
Learn More
Structural heart disease

Percutaneous Access Closure in TAVR: Are Devices Similar?

One of the challenges that transcatheter aortic valve replacement (TAVR) continues to face is percutaneous access closure...
solaci -
Learn More

SOLACI is the reference organization for Latin American cardiovascular interventionism.

Last News

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

Dr. Omar Tupayachi - 0
While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Dr. Andrés Rodríguez - 0
Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Dr. Omar Tupayachi - 0
Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....

Institutional News

Check out the best images of the El Salvador 2024 Sessions

solaci - 0
Review the highlights of the XLIX SOLACI Regional Sessions held at the Intercontinental Hotel in San Salvador, El Salvador between November 7 and 8,...

The El Salvador 2024 Sessions are coming soon

solaci - 0
The XLIX SOLACI 2024 Regional Sessions (17th Central America & the Caribbean) are approaching, and will take place in the city of San Salvador (El Salvador)....

Check out the best images of the Arequipa 2024 Sessions

solaci - 0
Review the highlights of the XVIII SOLACI Regional Sessions held at the Hanan Hotel in Arequipa, Peru between October 3 and 4, 2024. <!-- wp:tw/bwg...

Access

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Terms of Use -Privacy Policy